VASOCIDIN OPHTHALMIC SOLUTION
VASOCIDIN OPHTHALMIC SOLUTION
Discontinued
DIN Number
02133342
Drug Class
Human
Market Date
Dec 31, 1996
Company
HC
novartis ophthalmics novartis pharmaceuticals (canada) inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02133342
AIG Number0221618001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01CA02 PREDNISOLONE AND ANTIINFECTIVES
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:08.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
PREDNISOLONE SODIUM PHOSPHATEActive
Strength: 2.5 MG / ML
Monograph: PREDNISOLONE SODIUM PHOSPHATE
SULFACETAMIDE SODIUMActive
Strength: 100 MG / ML
Monograph: SULFACETAMIDE SODIUM